Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Virus Res

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    May 2017
  1. LI Y, Yan S, Li X, Yang Q, et al
    From mouse to pig: is PRV vaccine safe across two species?
    Virus Res. 2017 May 5. pii: S0168-1702(17)30197.
    PubMed     Text format     Abstract available


    April 2017
  2. MUNOZ-ALIA MA, Casasnovas JM, Celma ML, Carabana J, et al
    Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Virus Res. 2017 Apr 29. pii: S0168-1702(17)30127.
    PubMed     Text format     Abstract available


  3. FULTON RW, Neill JD, Saliki JT, Landis C, et al
    Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
    Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
    PubMed     Text format     Abstract available


    February 2017
  4. CZARNECKI MW, Traktman P
    The vaccinia virus DNA polymerase and its processivity factor.
    Virus Res. 2017 Feb 1. pii: S0168-1702(16)30833.
    PubMed     Text format     Abstract available


    January 2017
  5. STACHYRA A, Pietrzak M, Maciola A, Protasiuk A, et al
    A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Virus Res. 2017;232:41-47.
    PubMed     Text format     Abstract available


    December 2016
  6. YANG A, Farmer E, Lin J, Wu TC, et al
    The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Virus Res. 2016 Dec 5. pii: S0168-1702(16)30556.
    PubMed     Text format     Abstract available


    November 2016
  7. SCHELLENBACHER C, Roden RB, Kirnbauer R
    Developments in L2-based Human Papillomavirus (HPV) Vaccines.
    Virus Res. 2016 Nov 23. pii: S0168-1702(16)30528.
    PubMed     Text format     Abstract available


    September 2016
  8. ILLIANO E, Bissa M, Paolini F, Zanotto C, et al
    Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
    Virus Res. 2016;225:82-90.
    PubMed     Text format     Abstract available


    August 2016
  9. CRAWFORD K, Lager KM, Kulshreshtha V, Miller LC, et al
    Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada.
    Virus Res. 2016 Aug 18. pii: S0168-1702(16)30366.
    PubMed     Text format     Abstract available


  10. KIM BC, Kim DK, Kim HJ, Hong SH, et al
    A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine.
    Virus Res. 2016;223:190-196.
    PubMed     Text format     Abstract available


    July 2016
  11. ZUNIGA S, Pascual-Iglesias A, Sanchez CM, Sola I, et al
    VIRULENCE FACTORS IN PORCINE CORONAVIRUSES AND VACCINE DESIGN.
    Virus Res. 2016 Jul 7. pii: S0168-1702(16)30399.
    PubMed     Text format     Abstract available


    June 2016
  12. FULTON RW, d'Offay JM, Dubovi EJ, Eberle R, et al
    Bovine Herpesvirus-1: Genetic Diversity of Field Strains from Cattle with Respiratory Disease, Genital, Fetal Disease and Systemic Neonatal Disease and Their Relationship to Vaccine Strains.
    Virus Res. 2016 Jun 29. pii: S0168-1702(16)30231.
    PubMed     Text format     Abstract available


    May 2016
  13. LANGEL SN, Paim FC, Lager KM, Vlasova AN, et al
    Lactogenic Immunity and Vaccines for Porcine Epidemic Diarrhea Virus (PEDV): Historical And Current Concepts.
    Virus Res. 2016 May 19. pii: S0168-1702(16)30215.
    PubMed     Text format     Abstract available


  14. TERASAKI K, Tercero BR, Makino S
    Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Virus Res. 2016;216:55-65.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: